What affects bleeding control and how long you need to lie flat after femoral arterial sheath removal
Official title: Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients
Run by National Taiwan University Hospital · NCT07469397 · Data updated 2026-11-12
We will see if patient and procedure factors can predict how long ICU patients need compression and bed rest after femoral arterial sheath removal to prevent bleeding and hematoma.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 157 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | May 15, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 13, 2026 |
| Trial ID | NCT07469397 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (age ≥20) admitted to the cardiac ICU who undergo femoral arterial sheath removal and can tolerate lying flat with standard restraints.
✕Probably not a fit
Patients with active severe hematoma, vascular rupture at the puncture site, severe disseminated intravascular coagulation, or those unable or unwilling to remain supine with restraints are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study enrolling adult patients in the cardiac intensive care unit who undergo femoral arterial sheath removal. Investigators will use direct inspection at the bedside and review medical records to collect clinical, procedural, and laboratory variables (for example anticoagulation status, sheath size, procedure type, and initial hemostasis time). They will analyze which factors are associated with failure of initial hemostasis, hematoma formation, and the required duration of compression and supine time. The goal is to develop more accurate, evidence-based guidance on how long to maintain compression and bed rest to reduce complications and patient discomfort.
Why it matters
Potential benefit: If successful, the findings could shorten unnecessary bed rest and reduce pain, urinary problems, and bleeding-related complications after sheath removal.
How similar studies have gone: Previous research on predictors of post‑sheath bleeding and optimal supine time is limited and inconsistent, so this approach is not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients admitted to the cardiac intensive care unit of this hospital. 2. Patients undergoing femoral arterial sheath removal. 3. Age 20 years or older. Exclusion Criteria: 1. Patients unable to maintain supine position or refusing physical restraints. 2. Patients with severe hematoma, vascular rupture, or other vascular complications present at the femoral arterial puncture site at the time of sheath insertion. 3. Patients with a diagnosis of severe disseminated intravascular coagulation (DIC).
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Pou Yun Wang
- Email: unique201001@gmail.com
- Phone: 0965729268
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
Long-term P2Y12 inhibitor monotherapy and blood clotting after angioplasty
This trial will test whether specific P2Y12 drugs and reduced doses given alone keep platelet activity in a safe therapeutic range for people who completed initial dual antiplatelet therapy after PCI.
-
Doctors' and patients' preferences for PCI implantation devices
This questionnaire tests what patients who have had PCI and the doctors who treat them prefer between drug-eluting stents and drug-coated balloons.
-
How patients and doctors value different outcomes after coronary stent procedures
This project asks patients who had a coronary stent (PCI) and the doctors who treat them to rate how important different possible outcomes are to see if their priorities match.
-
Flozins to prevent contrast-related kidney injury after coronary angiography or PCI
This project tests whether taking a flozin (empagliflozin or dapagliflozin), short-term or long-term, lowers the chance of contrast-induced acute kidney injury in patients having coronary angiography or PCI.
-
Temporary heart support with the iVAC 2L device during high-risk coronary procedures
This trial will try the iVAC 2L temporary heart‑support device during high‑risk PCI to help people with severe coronary artery disease stay hemodynamically stable through the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.